Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure

about

Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure

Item

http://www.wikidata.org/entity/Q56373543

description

scientific article published on 30 May 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Amyloid positron emission tomo ...... an risks of results disclosure

@en

Amyloid positron emission tomo ...... an risks of results disclosure

@nl

type

Item

label

Amyloid positron emission tomo ...... an risks of results disclosure

@en

Amyloid positron emission tomo ...... an risks of results disclosure

@nl

prefLabel

Amyloid positron emission tomo ...... an risks of results disclosure

@en

Amyloid positron emission tomo ...... an risks of results disclosure

@nl

P1476

Amyloid positron emission tomo ...... an risks of results disclosure

@en

P2093

Eric McDade

http://www.w3.org/2001/XMLSchema#string

Hyejin Kim

http://www.w3.org/2001/XMLSchema#string

J Scott Roberts

http://www.w3.org/2001/XMLSchema#string

Jennifer H Lingler

http://www.w3.org/2001/XMLSchema#string

Jonna L Morris

http://www.w3.org/2001/XMLSchema#string

Meghan Mattos

http://www.w3.org/2001/XMLSchema#string

Oscar L Lopez

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

Living With Ambiguity: A Metasynthesis of Qualitative Research on Mild Cognitive Impairment

Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Communicating mild cognitive impairment diagnoses with and without amyloid imaging.

Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.

Unwarranted variations in healthcare delivery: implications for academic medical centres

Amnestic MCI Patients' Perspectives toward Disclosure of Amyloid PET Results in a Research Context.

Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials

Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada

P304

413-420

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DADM.2018.05.003

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lu Hu

P577

2018-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30094328

http://www.w3.org/2001/XMLSchema#string

P932

6072672

http://www.w3.org/2001/XMLSchema#string